Primitiv Group Revenue and Competitors

Our mission is this: to act as a leading light in the cannabis industry by supporting efforts to provide holistic relief for patients who struggle with chronic illness and pain, while educating the public on the health benefits of marijuana. Through our partnerships with institutions such as the International Phytomedicines and Medical Cannabis Institute at Harvard University, Primitiv works to expand research and disseminate information into the health benefits of cannabis on a wide range of medical conditions, including chronic pain, CTE (chronic traumatic encephalopathy), and cancer treatments. We believe that this plant holds incredible potential as a healing agent, and Primitiv will continue doing the research and collecting the data that will lead to the best and most consistent treatment options available in the market.